Sanprobi Femi+ ginekologiczny probiotyk menu

Dla profesjonalistów

1. Polecane publikacje naukowe:

  • Reid G, Younes JA, Van der Mei HC, Gloor GB, Knight R, Busscher HJ.Microbiota restoration: natural and supplemented recovery of human microbial communities.Nat Rev Microbiol. 2011 Jan;9(1):27-38. doi: 10.1038/nrmicro2473.
  • Blaskewicz CD, Pudney J, Anderson DJ. Structure and function of intercellular junctions in human cervical and vaginal mucosal epithelia. Biol Reprod. 2011 Jul;85(1):97-104. doi: 10.1095/biolreprod.110.090423 (FREE)
  • Petrova MI, van den Broek M, Balzarini J, Vanderleyden J, Lebeer S.Vaginal microbiota and its role in HIV transmission and infection. FEMS Microbiol Rev. 2013;37(5):762-92. doi: 10.1111/1574-6976.12029. (FREE)
  • Reid G, Kumar H, Khan AI, Rautava S, Tobin J, Salminen S: The case in favour of probiotics before, during and after pregnancy: insights from the first 1,500 days. Benef Microbes. 2016: 1-10.

  • Onderdonk AB, Delaney ML, Fichorova RN: The Human Microbiome during Bacterial Vaginosis. Clin Microbiol Rev. 2016; 29 (2): 223-38.

  • Faure E, Faure K, Figeac M, Kipnis E, Grandjean T, Dubucquoi S, Villenet C, Grandbastien B, Brabant G, Subtil D, Dessein R: Vaginal Mucosal Homeostatic Response May Determine Pregnancy Outcome in Women With Bacterial Vaginosis: A Pilot Study. Medicine (Baltimore). 2016; 95 (5): e2668.

  • Mitra A, MacIntyre DA, Lee YS, Smith A, Marchesi JR, Lehne B, Bhatia R, Lyons D, Paraskevaidis E, Li JV, Holmes E, Nicholson JK, Bennett PR, Kyrgiou M: Cervical intraepithelial neoplasia disease progression is associated with increased vaginal microbiome diversity. Sci Rep. 2015; 5: 16865.

  • Kovachev SM, Vatcheva-Dobrevska RS: Local Probiotic Therapy for Vaginal Candida albicans Infections. Probiotics Antimicrob Proteins. 2015; 7 (1): 38-44.

  • Green KA, Zarek SM, Catherino WH: Gynecologic health and disease in relation to the microbiome of the female reproductive tract. Fertil Steril. 2015; 104 (6): 1351-7

  • Witkin SS: The vaginal microbiome, vaginal anti-microbial defence mechanisms and the clinical challenge of reducing infection-related preterm birth. BJOG. 2015; 122 (2): 213-8.

  • Prince AL, Chu DM, Seferovic MD, Antony KM, Ma J, Aagaard KM: The perinatal microbiome and pregnancy: moving beyond the vaginal microbiome. Cold Spring Harb Perspect Med. 2015; 5 (6)

  • Pines A: Microbiotica in women. Climacteric. 2015;18 (5): 666-8

  • Borges S, Silva J, Teixeira P: The role of lactobacilli and probiotics in maintaining vaginal health. Arch Gynecol Obstet. 2014; 289 (3): 479-89

  • Kovachev SM: Obstetric and gynecological diseases and complications resulting from vaginal dysbacteriosis. Microb Ecol. 2014; 68 (2): 173-84

  • Vicariotto F, Mogna L, Del Piano M: Effectiveness of the two microorganisms Lactobacillus fermentum LF15 and Lactobacillus plantarum LP01, formulated in slow-release vaginal tablets, in women affected by bacterial vaginosis: a pilot study. J Clin Gastroenterol. 2014; 48 Suppl 1: S106-12

  • Fredricks DN, Fiedler TL, Marrazzo JM: Molecular identification of bacteria associated with bacterial vaginosis. N Engl J Med. 2005; 353 (18): 1899-911

2. Prezentacja dotycząca wyrobu medycznego SANPROBI FEMI +

 

3. Polecane strony

Women and Their Microbes: http://womenandtheirmicrobes.com/

 

 4. Polecane materiały multimedialne